Published in J Natl Cancer Inst on April 04, 2001
Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect (2003) 2.27
Clinical epidemiology of testicular germ cell tumors. World J Urol (2004) 1.92
An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol (2007) 1.83
Etiologic factors in testicular germ-cell tumors. Future Oncol (2009) 1.44
Estrogen regulation of testicular function. Reprod Biol Endocrinol (2005) 1.17
Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med (2014) 1.03
Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer (2002) 1.01
Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis. Environ Health Perspect (2008) 0.99
Conditions in utero and cancer risk. Eur J Epidemiol (2006) 0.98
Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism. Endocr Rev (2014) 0.97
Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects. Birth Defects Res C Embryo Today (2013) 0.96
Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health (2009) 0.96
Estrogenic exposure alters the spermatogonial stem cells in the developing testis, permanently reducing crossover levels in the adult. PLoS Genet (2015) 0.93
Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES). Int J Androl (2009) 0.92
Diethylstilboestrol exposure does not reduce testosterone production in human fetal testis xenografts. PLoS One (2013) 0.89
Use of clomifene during early pregnancy and risk of hypospadias: population based case-control study. BMJ (2004) 0.88
Environmental endocrine disruptors: Effects on the human male reproductive system. Rev Endocr Metab Disord (2015) 0.83
TRA-1-60(+), SSEA-4(+), POU5F1(+), SOX2(+), NANOG(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes. J Stem Cell Res Ther (2013) 0.83
Effect of high intratesticular estrogen on global gene expression and testicular cell number in rats. Reprod Biol Endocrinol (2010) 0.80
Cytochrome P450 aromatase expression in human seminoma. Reprod Biol Endocrinol (2005) 0.79
[Molecular pathology of testicular germ cell tumors: an update]. Pathologe (2008) 0.78
Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis. Asian J Androl (2015) 0.78
Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia. Reprod Biol Endocrinol (2009) 0.78
Nuclear receptors and endocrine disruptors in fetal and neonatal testes: a gapped landscape. Front Endocrinol (Lausanne) (2015) 0.77
Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families. Cancer Med (2015) 0.76
Speciation, phenotypic variation and plasticity: what can endocrine disruptors tell us? Int J Endocrinol (2013) 0.75
Pregnant "DES daughters" and their offspring. Can Fam Physician (2005) 0.75
Germline and reproductive tract effects intensify in male mice with successive generations of estrogenic exposure. PLoS Genet (2017) 0.75
[Carcinoma in situ of the testis: predisposition, evolution and early detection]. Pathologe (2011) 0.75
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med (1971) 11.95
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72
Cellular-telephone use and brain tumors. N Engl J Med (2001) 5.57
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1996) 3.76
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 3.40
The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc (1995) 3.12
HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96
A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol (1968) 2.92
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci U S A (1991) 2.74
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA (1994) 2.71
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol (1985) 2.65
Random digit dialing in selecting a population-based control group. Am J Epidemiol (1984) 2.64
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation (1996) 2.64
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
The emerging epidemic of melanoma and squamous cell skin cancer. JAMA (1989) 2.61
Mammographic densities and risk of breast cancer. Cancer (1991) 2.47
Compilation and analysis of intein sequences. Nucleic Acids Res (1997) 2.46
Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol (1970) 2.45
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer (1970) 2.44
Artificial sweeteners and human bladder cancer. Preliminary results. Lancet (1980) 2.42
Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med (1992) 2.34
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med (1972) 2.11
Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol (1993) 2.07
Follow-up of a large cohort of Black women. Am J Epidemiol (2001) 2.05
Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst (1995) 2.03
Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology (2001) 1.96
Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med (1990) 1.95
A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med (1978) 1.95
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med (1987) 1.87
Disseminated intravascular coagulation (DIC): an approach. Am J Med (1972) 1.87
Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst (1990) 1.86
Vasectomy and the risk of prostate cancer. Am J Epidemiol (1990) 1.84
Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82
Breast cancer risk factors among screening program participants. J Natl Cancer Inst (1979) 1.81
Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80
A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet (1997) 1.79
Antigenic differences between isolates of herpesvirus type 2. Intervirology (1974) 1.79
Calcium channel blockers and the risk of cancer. JAMA (1998) 1.78
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol (1992) 1.77
Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med (1995) 1.76
Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology (1997) 1.76
Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst (1996) 1.76
Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer (2000) 1.73
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1994) 1.73
Evidence of a healthy estrogen user survivor effect. Epidemiology (1995) 1.72
Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol (2001) 1.72
Urinary tract infection and risk of bladder cancer. Am J Epidemiol (1984) 1.70
Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol (1972) 1.68
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64
Mortality among augmentation mammoplasty patients. Epidemiology (2001) 1.60
Over-the-counter analgesics and risk of ovarian cancer. Lancet (1998) 1.59
Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol (1977) 1.57
The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis (1989) 1.57
Factors influencing the age at natural menopause. J Chronic Dis (1987) 1.57
Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey. Lancet (1987) 1.57
Risk factors for cancer of the testis. N Engl J Med (1980) 1.57
Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta (2005) 1.56
Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev (1999) 1.56
Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control (2000) 1.56
Occupational risks of bladder cancer in the United States: I. White men. J Natl Cancer Inst (1989) 1.55
Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control (1995) 1.55
Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases. Cancer (1983) 1.54
Bowel perforation with suprapubic cystostomy Report of two cases. Obstet Gynecol (1976) 1.54
Human papillomavirus and herpes simplex virus in vulvar squamous cell carcinoma in situ. Am J Obstet Gynecol (1988) 1.54
Is human papillomavirus testing of value in clinical practice? Am J Obstet Gynecol (1999) 1.54
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54
Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol (1986) 1.54
Autopsy findings with permanent pervenous pacemakers. Circulation (1969) 1.53
Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. J Natl Cancer Inst (1978) 1.53
High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet (1987) 1.52
Testicular cancer in the United States: trends in incidence and mortality. Int J Epidemiol (1986) 1.52
Human papillomavirus infection. Frequency and association with cervical neoplasia in a young population. Acta Cytol (1989) 1.52
A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med (2000) 1.52
Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer (1977) 1.51
A comparison of intrauterine versus intracervical insemination in fertile single women. Fertil Steril (2001) 1.51
Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control (1993) 1.51
Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst (1995) 1.50
Correlates of postmenopausal female hormone use among black women in the United States. Obstet Gynecol (1998) 1.49
Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst (1990) 1.49